Pharmacokinetics of a new long acting endectocide formulation containing 2.25% ivermectin and 1.25% abamectin in cattle

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue 1, 2007, Pages 62-67

  Borges, F A ^a,b   Cho, H S ^c   Santos, E ^d   Oliveira, G P ^a   Costa, A J ^a,b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b CPPAR ^*

^c Intervet Do Brasil Veterinária Ltda

^d INTERVET INTERNATIONAL BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABAMECTIN; GLYCEROL FORMAL; IVERMECTIN; OIL; PROPYLENE GLYCOL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG HALF LIFE; FEMALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; PRIORITY JOURNAL; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTHELMINTICS; AREA UNDER CURVE; CATTLE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; FEMALE; INJECTIONS, SUBCUTANEOUS; IVERMECTIN;

BOS TAURUS;

EID: 33846110877     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00816.x     Document Type: Article

References (30)

1. Alka, R.M., Gopal, R.M., Sandhu, K.S. & Sidhu, P.K. (2004) Efficacy of abamectin against ivermectin-resistant strain of Trichostrongylus colubriformis in sheep. Veterinary Parasitology, 121, 277-283.
2. Blackhall, W.J., Liu, H.Y., Xu, M., Prichard, R.K. & Beech, R.N. (1998) Selection at a P-glycoprotein gene in ivermectin- and moxidectin-selected strains of Haemonchus contortus. Molecular and Biochemical Parasitology, 95, 193-201.
3. Campbell, W.C. & Benz, G.W. (1984) Ivermectin: a review of efficacy and safety. Journal of Veterinary Pharmacology and Therapeutics, 7, 1-16.
4. Campbell, W.C., Fisher, M.H., Stapley, E.O., Albers-Schonberg, G. & Jacobs, T.A. (1983) Ivermectin: a potent new antiparasitic agent. Science, 221, 823-828.
5. Cerkvenik Flajs, V. & Grabnar, I. (2002) Ivermectin pharmacokinetics. Slovenian Veterinary Research, 39, 167-178.
6. Chabala, J.C., Mrozik, H., Tolman, R.L., Eskola, P., Lusi, A., Peterson, L.H., Woods, M.F. & Fisher, M.H. (1980) Ivermectin, a new broad-spectrum antiparasitic agent. Journal of Medicinal Chemistry, 23, 1134-1136.
7. Chiu, S.H.L., Green, M.L., Baylis, F.P., Eline, D., Rosegay, A., Meriwether, H. & Jacob, T.A. (1990) Absorption, tissue distribution and excretion of tritium-labeled ivermectin in cattle, sheep and rat. Journal of Agriculture Food and Chemistry, 38, 2072-2078.
8. Conder, G.A., Thompson, D.P. & Johnson, S.S. (1993) Demonstration of co-resistance of Haemonchus contortus to ivermectin and moxidectin. The Veterinary Record, 132, 651-652.
9. Costa, A.J., Borges, F.A., Oliveira, G.P., Martins, J.R., Silva, H.C., Barufi, F.B., Santos, E. & Cho, H.S. (2005) Pharmacokinetics and endectocide activity of an antiparasitic innovation (ivermectin + abamectin): results of 14 experimental evaluations. Proceedings of the 20th International Conference of the World Association for the Advancement of Veterinary Parasitology, pp. 79, Christchurch, New Zealand.
10. Echevarria, J., Mestorino, N., Giorgieri, S., Turic, E., Alt, M. & Errecalda, J. (1997) Pharmacokinetics of ivermectin after intravenous and subcutaneous administration to cattle. Journal of Veterinary Pharmacology and Therapeutics, 20, 77-78.
11. 1, a new broad-spectrum antiparasitic agent. British Veterinary Journal, 136, 88-97.
12. Fink, D. & Porras, A. (1989) Pharmacokinetics of ivermectin in experimentally infected cattle. In Ivermectin and Abamectin, Ed. Campbell, W.C., pp. 90-113. Springer-Verlag, New York.
13. Gayard, V., Alvinerie, M. & Toutain, P.L. (1999) Comparison of pharmacokinetic profiles of doramectin and ivermectin pour on formulations in cattle. Veterinary Parasitology, 81, 47-55.
14. Geary, T.G. & Thompson, D.P. (2003) Development of antiparasitic drugs in the 21st century. Veterinary Parasitology, 115, 167-184.
15. Geary, T.G., Sangster, N.C. & Thompson, D.P. (1999) Frontiers in anthelmintic pharmacology. Veterinary Parasitology, 84, 275-295.
16. Gibaldi, M. & Perrier, D. (1982) Pharmacokinetics, Revised and Expanded, 2nd edn, 494 pp. Marcel Dekker, Inc., New York.
17. Herd, R.P., Sams, R.A. & Ashcroft, S.M. (1996) Persistence of ivermectin in plasma and faeces following treatment of cows with ivermectin sustained-release, pour-on or injectable formulations. International Journal for Parasitology, 26, 1087-1093.
18. Jackson, H. (1989) Ivermectin as a systemic insecticide. Parasitology Today, 5, 146-155.
19. Lanusse, C. & Prichard, R. (1993) Relationship between pharmacological properties and clinical efficacy of ruminant anthelmintics. Veterinary Parasitology, 48, 123-158.
20. Lanusse, C., Lifschitz, A., Virkel, G., Alvarez, L., Sanchez, S., Sutra, J.F., Galtier, P. & Alvinerie, M. (1997) Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle. Journal of Veterinary Pharmacology and Therapeutics, 20, 91-99.
21. Leathwick, D.M., Moen, I.C., Miller, C.M. & Sutherland, I.A. (2000) Ivermectin-resistant Ostertagia circumcincta from sheep in the lower North Island and their susceptibility to other macrocyclic lactone anthelmintics. New Zealand Veterinary Journal, 48, 151-154.
22. Lifschitz, A., Virkel, G., Pis, A., Imperiale, F., Sanchez, S., Alvarez, L., Kujanek, R. & Lanusse, C. (1999) Ivermectin disposition kinetics after subcutaneous and intramuscular administration of an oil-based formulation to cattle. Veterinary Parasitology, 86, 203-215.
23. Lifschitz, A., Sallovitz, J., Imperiale, F., Pis, A., Jauregui Lorda, J. & Lanusse, C. (2004) Pharmacokinetic evaluation of four ivermectin generic formulations in calves. Veterinary Parasitology, 119, 247-257.
24. Lo, P., Fink, D., Williams, J. & Blodinger, J.P. (1985) Pharmacokinetics studies of ivermectin: effect of formulation. Veterinary Research Communications, 9, 251-268.
25. Statistical Analysis System (1989-1996) SAS® User's Guide: Statistics. SAS Institute, Inc., Cary, NC.
26. Shoop, W.L. & Soll, M. (2002) Chemistry, pharmacology and safety of the macrocyclic lactones. In Macrocyclic Lactones in Antiparasitic Therapy, Eds Vercruysse, J. & Rew, R.S., pp. 1-29. CAB International, Wallingford, UK.
27. Torrano, C. (2003) Mode of Action and Resistance Mechanisms of Moxidectin and Macrocyclic Lactones. Proceedings of the V International Seminar in Animal Parasitology, pp. 105-113. Merida, Mexico.
28. Toutain, P.L., Campan, M., Galtier, P. & Alvinerie, M. (1988) Kinetics and insecticidal properties of ivermectin residues in the milk of dairy cows. Journal of Veterinary Pharmacology and Therapeutics, 11, 288-291.
29. Toutain, P.L., Upson, D.W., Terhune, T.N. & McKenzie, M.E. (1997) Comparative pharmacokinetics of doramectin and ivermectin in cattle. Veterinary Parasitology, 72, 3-8.
30. Watson, T.G., Hosking, B.C., Leathwick, D.M. & McKee, P.F. (1996) Ivermectin-moxidectin side resistance by Ostertagia species isolated from goats and passaged to sheep. The Veterinary Record, 138, 472-473.